Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study)

M. Julsgaard, L. A. Christensen, P. R. Gibson, J. Fallingborg, R. Gearry, A. Walsh, Jens Kjeldsen, W. Connell, M. P. Sparrow, G. Radford-Smith, J. M. Andrews, S. J. Connor, I. Lawrence, S. Wildt, G. T. Moore, L. Svenningsen, O. Rosella, A. Grosen, S. J. Bell

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftJournal of Gastroenterology and Hepatology
Vol/bind29
Udgave nummerS2
Sider (fra-til)117-118
ISSN0815-9319
DOI
StatusUdgivet - 2014
BegivenhedAustralian Gastroenterology Week - Gold Coast Convention & Exhibition Centre, Broadbeach, Queensland, Australien
Varighed: 22. okt. 201424. okt. 2014

Konference

KonferenceAustralian Gastroenterology Week
LokationGold Coast Convention & Exhibition Centre
LandAustralien
ByBroadbeach, Queensland
Periode22/10/201424/10/2014

Citationsformater

Julsgaard, M., Christensen, L. A., Gibson, P. R., Fallingborg, J., Gearry, R., Walsh, A., Kjeldsen, J., Connell, W., Sparrow, M. P., Radford-Smith, G., Andrews, J. M., Connor, S. J., Lawrence, I., Wildt, S., Moore, G. T., Svenningsen, L., Rosella, O., Grosen, A., & Bell, S. J. (2014). Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study). Journal of Gastroenterology and Hepatology, 29(S2), 117-118. https://doi.org/10.1111/jgh.12736_6